Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities
Introduction: Racial minority groups have been disproportionately affected by the 2019 novel coronavirus disease (COVID-19). Vaccine hesitancy may be a major barrier to achieving equitable herd immunity and must be addressed to reduce the excess morbidity and mortality of COVID-19 in disproportionat...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ad5f9ac0707043b499a778dcceb3e90b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ad5f9ac0707043b499a778dcceb3e90b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ad5f9ac0707043b499a778dcceb3e90b2021-11-30T17:58:59ZVaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities2296-858X10.3389/fmed.2021.668299https://doaj.org/article/ad5f9ac0707043b499a778dcceb3e90b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.668299/fullhttps://doaj.org/toc/2296-858XIntroduction: Racial minority groups have been disproportionately affected by the 2019 novel coronavirus disease (COVID-19). Vaccine hesitancy may be a major barrier to achieving equitable herd immunity and must be addressed to reduce the excess morbidity and mortality of COVID-19 in disproportionately affected communities. This study aimed to determine if COVID-19 vaccine hesitancy, and its factors vaccine complacency and confidence, are more prominent among disproportionately affected racial minority groups.Methods:We collected data from participants aged 18 years or older from the four most populous U.S. states, including New York, California, Florida, and Texas, and Canada. Data were collected using a web-based survey platform. Data are available at http://www.covid19-database.com.Results:Data from 4,434 participants were included [mean (SD) age = 48.7 (17.2) and 50.4% women]. Vaccine hesitancy was higher in Black, Indigenous (Native American and Indigenous People of Canada, including First Nations, Inuit and Métis), and Latinx compared to White participants, while no difference was found between East Asian and White participants. The group differences in vaccine hesitancy for Indigenous and Black compared to White participants remained after controlling for sociodemographic factors. Determinants of vaccine complacency were equivalent between disproportionately affected racial groups and white participants. Vaccine confidence (i.e., trust in vaccine benefit) was generally lower in all racial groups compared to White participants. Differences in vaccine mistrust comparing Black and East Asian to White participants remained after controlling for sociodemographic factors.Discussion:Disproportionately affected racial minorities may have higher vaccine hesitancy and lower confidence in COVID-19 vaccines. Public health and other relevant government services should address vaccine hesitancy among racial minorities using a culturally sensitive, community-centered approach to attain equitable herd immunity.Philip GerretsenJulia KimLena QuiltySamantha WellsEric E. BrownBranka AgicBruce G. PollockAriel Graff-GuerreroFrontiers Media S.A.articleCOVID-19racial minoritiesherd immunityvaccine hesitancyvaccine acceptance3C modelMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
COVID-19 racial minorities herd immunity vaccine hesitancy vaccine acceptance 3C model Medicine (General) R5-920 |
| spellingShingle |
COVID-19 racial minorities herd immunity vaccine hesitancy vaccine acceptance 3C model Medicine (General) R5-920 Philip Gerretsen Julia Kim Lena Quilty Samantha Wells Eric E. Brown Branka Agic Bruce G. Pollock Ariel Graff-Guerrero Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| description |
Introduction: Racial minority groups have been disproportionately affected by the 2019 novel coronavirus disease (COVID-19). Vaccine hesitancy may be a major barrier to achieving equitable herd immunity and must be addressed to reduce the excess morbidity and mortality of COVID-19 in disproportionately affected communities. This study aimed to determine if COVID-19 vaccine hesitancy, and its factors vaccine complacency and confidence, are more prominent among disproportionately affected racial minority groups.Methods:We collected data from participants aged 18 years or older from the four most populous U.S. states, including New York, California, Florida, and Texas, and Canada. Data were collected using a web-based survey platform. Data are available at http://www.covid19-database.com.Results:Data from 4,434 participants were included [mean (SD) age = 48.7 (17.2) and 50.4% women]. Vaccine hesitancy was higher in Black, Indigenous (Native American and Indigenous People of Canada, including First Nations, Inuit and Métis), and Latinx compared to White participants, while no difference was found between East Asian and White participants. The group differences in vaccine hesitancy for Indigenous and Black compared to White participants remained after controlling for sociodemographic factors. Determinants of vaccine complacency were equivalent between disproportionately affected racial groups and white participants. Vaccine confidence (i.e., trust in vaccine benefit) was generally lower in all racial groups compared to White participants. Differences in vaccine mistrust comparing Black and East Asian to White participants remained after controlling for sociodemographic factors.Discussion:Disproportionately affected racial minorities may have higher vaccine hesitancy and lower confidence in COVID-19 vaccines. Public health and other relevant government services should address vaccine hesitancy among racial minorities using a culturally sensitive, community-centered approach to attain equitable herd immunity. |
| format |
article |
| author |
Philip Gerretsen Julia Kim Lena Quilty Samantha Wells Eric E. Brown Branka Agic Bruce G. Pollock Ariel Graff-Guerrero |
| author_facet |
Philip Gerretsen Julia Kim Lena Quilty Samantha Wells Eric E. Brown Branka Agic Bruce G. Pollock Ariel Graff-Guerrero |
| author_sort |
Philip Gerretsen |
| title |
Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| title_short |
Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| title_full |
Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| title_fullStr |
Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| title_full_unstemmed |
Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities |
| title_sort |
vaccine hesitancy is a barrier to achieving equitable herd immunity among racial minorities |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/ad5f9ac0707043b499a778dcceb3e90b |
| work_keys_str_mv |
AT philipgerretsen vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT juliakim vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT lenaquilty vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT samanthawells vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT ericebrown vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT brankaagic vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT brucegpollock vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities AT arielgraffguerrero vaccinehesitancyisabarriertoachievingequitableherdimmunityamongracialminorities |
| _version_ |
1718406401453195264 |